Workit Health Valuation, Funding & Investors

Slingshot AI is a New York and London-based AI research firm developing tools to expand mental health access amid a 10,000:1 provider shortage. The team builds psychology-informed models for personalized interventions, serving users via apps since 2023 with cross-disciplinary expertise from clinicians and engineers.

Doktor.se is a Stockholm-based digital healthcare provider delivering remote consultations via app with nurses, doctors, and psychologists. Services include prescriptions, referrals, and primary care from Swedish offices. Founded in 2016, Doktor.se holds approvals from regional health authorities for nationwide coverage.

Found is a San Francisco-headquartered telehealth company founded in 2019 that prescribes GLP-1 medications like semaglutide for weight loss. It partners with U.S. pharmacies for compounded drugs and serves members across 50 states with virtual coaching and tracking tools.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company’s operations and revenues are based in the United States.

Forward is a San Francisco-headquartered healthcare provider founded in 2016 by Adrian Aoun and former Google and Uber leaders. It deploys sensors, mobile apps, and AI for proactive health monitoring in membership-based clinics. Backed by First Round Capital, Eric Schmidt, Marc Benioff, Joe Lonsdale, Joshua Kushner, and Garrett Camp, the company operates facilities in California and beyond, emphasizing preventive care over traditional visits.

Midi Health is a telehealth provider specializing in women's midlife care, including menopause, perimenopause, hormonal imbalances, weight management, mood disorders, sleep issues, hair and skin health, sexual wellness, and cancer survivorship. Headquartered in San Francisco, it connects patients with board-certified clinicians via virtual visits covered by major insurers like Aetna and Blue Cross. Midi partners with employers such as Lyft and health systems to integrate services, offering custom prescriptions, metabolic testing, and supplements shipped nationwide.

Headspace is a global mental health platform available through headspace.com, combining meditation, mindfulness exercises, self-guided care paths, coaching, and therapy in a single app. It partners with employers, health plans, and organizations to deliver psychiatry, employee assistance programs, care navigation, and work-life services. Headspace employs clinicians, content producers, and data scientists to serve users worldwide with personalized resilience-building programs.

Hims & Hers is a San Francisco-headquartered telehealth platform connecting patients with licensed providers for treatments in hair loss, erectile dysfunction, mental health, dermatology, and weight management. Founded in 2017 and public on NYSE since 2021, it serves 1.5 million subscribers through its proprietary electronic health record system. Partnerships with Ochsner Health, Mount Sinai, and Privia Health enable hybrid virtual and in-person care, with Hers brand launched in 2018 expanding women's health options like skincare and birth control.

SonderMind is a Denver-headquartered teletherapy platform founded in 2017 that matches patients with licensed therapists across 50 states. Its network includes 3,000 providers specializing in anxiety, depression, and trauma, serving 200,000 sessions monthly for individuals, employers, and health plans like Aetna. The platform handles billing, scheduling, and outcomes tracking via HIPAA-compliant software. SonderMind operates in partnership with 100 corporate clients and reports 85 percent client retention through personalized matching algorithms.

Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.

Elemy is a provider of in-home behavioral and mental healthcare for children nationwide. Denver-headquartered, it launched autism care services in April 2020 before expanding to ADHD, OCD, anxiety, depression, social anxiety, and bipolar disorder. The platform integrates telehealth scheduling, progress tracking, and multidisciplinary teams of therapists, behavior analysts, and psychiatrists delivering whole-child treatment models. Elemy partners with insurers like UnitedHealthcare and Aetna, focusing on underserved families in 25 states with outcomes including doubled therapy adherence rates.

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.